Illumina (ILMN) Competitors $100.34 +2.19 (+2.23%) Closing price 04:00 PM EasternExtended Trading$100.89 +0.55 (+0.55%) As of 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ILMN vs. A, MTD, WAT, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMOShould you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Illumina vs. Its Competitors Agilent Technologies Mettler-Toledo International Waters Bio-Techne Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies (NYSE:A) and Illumina (NASDAQ:ILMN) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends. Does the media prefer A or ILMN? In the previous week, Illumina had 2 more articles in the media than Agilent Technologies. MarketBeat recorded 19 mentions for Illumina and 17 mentions for Agilent Technologies. Illumina's average media sentiment score of 1.43 beat Agilent Technologies' score of 1.34 indicating that Illumina is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 13 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Illumina 17 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, A or ILMN? Agilent Technologies has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500. Comparatively, Illumina has a beta of 1.36, meaning that its share price is 36% more volatile than the S&P 500. Is A or ILMN more profitable? Agilent Technologies has a net margin of 17.59% compared to Illumina's net margin of -22.25%. Agilent Technologies' return on equity of 25.92% beat Illumina's return on equity.Company Net Margins Return on Equity Return on Assets Agilent Technologies17.59% 25.92% 13.24% Illumina -22.25%25.54%8.62% Do analysts prefer A or ILMN? Agilent Technologies presently has a consensus target price of $140.92, indicating a potential upside of 16.51%. Illumina has a consensus target price of $127.39, indicating a potential upside of 26.96%. Given Illumina's higher possible upside, analysts plainly believe Illumina is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agilent Technologies 0 Sell rating(s) 6 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.54Illumina 1 Sell rating(s) 9 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.47 Which has higher earnings and valuation, A or ILMN? Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgilent Technologies$6.51B5.28$1.29B$4.0529.86Illumina$4.34B3.66-$1.22B-$6.07-16.53 Do insiders & institutionals have more ownership in A or ILMN? 89.4% of Illumina shares are owned by institutional investors. 2.6% of Illumina shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryAgilent Technologies beats Illumina on 9 of the 17 factors compared between the two stocks. Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ILMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ILMN vs. The Competition Export to ExcelMetricIlluminaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.88B$2.90B$5.49B$8.94BDividend YieldN/A2.69%5.38%4.12%P/E Ratio-16.5321.3126.2119.90Price / Sales3.66275.59415.38165.30Price / Cash20.3441.8936.4957.06Price / Book6.717.518.055.38Net Income-$1.22B-$55.05M$3.15B$248.50M7 Day Performance7.63%2.45%1.85%2.97%1 Month Performance23.74%7.33%4.81%6.02%1 Year Performance-4.90%5.38%34.86%20.39% Illumina Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ILMNIllumina4.8711 of 5 stars$100.34+2.2%$127.39+27.0%-7.0%$15.88B$4.34B-16.539,030AAgilent Technologies4.6959 of 5 stars$118.06-0.9%$140.92+19.4%-5.6%$33.54B$6.51B29.1518,100Positive NewsMTDMettler-Toledo International4.2626 of 5 stars$1,175.56-0.8%$1,300.36+10.6%-11.9%$24.43B$3.87B29.3218,000Positive NewsWATWaters4.0055 of 5 stars$349.93-0.7%$388.00+10.9%+26.1%$20.82B$2.96B31.758,200Trending NewsTECHBio-Techne4.975 of 5 stars$51.45-0.8%$72.00+39.9%-27.3%$8.07B$1.16B62.743,100Positive NewsCRLCharles River Laboratories International4.0308 of 5 stars$151.64+1.1%$171.85+13.3%-23.8%$7.45B$4.05B-233.2920,100Positive NewsBIOBio-Rad Laboratories4.9006 of 5 stars$241.65-1.0%$324.25+34.2%-5.9%$6.58B$2.57B-3.177,700Positive NewsBRKRBruker4.7495 of 5 stars$41.20-1.4%$52.89+28.4%-32.8%$6.24B$3.45B79.2311,396PACBPacific Biosciences of California2.1609 of 5 stars$1.24-3.9%$2.06+66.2%+7.5%$372.10M$154.01M-0.44730Positive NewsGap DownHBIOHarvard Bioscience4.1134 of 5 stars$0.44-4.3%$3.00+576.0%-83.9%$19.62M$94.14M-0.34490TMOThermo Fisher Scientific4.9941 of 5 stars$405.83-0.6%$604.05+48.8%-22.2%$153.20B$42.88B23.80125,000Positive News Related Companies and Tools Related Companies Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ILMN) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredSomething very strange is happening...What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
